Inflammatory Bowel Disease Flashcards

1
Q

A good bowel history.

A

How often are they going to the toilet?

Changed from usual?

Has the form changed?

Are they waking overnight to go to the bathroom?

Is there any blood in stools?

Do they have tenesmus?

Do they have faecal urgency?

To they have faecal incontinence?

Is it foul smelling/float/does it easily flush?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Two main types of IBD.

A

Ulcerative colitis

Crohn’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Investigations in IBD.

A

Bloods - FBC, U&Es and CRP

Stools - Cultures (exclude infective colitis) and Faecal calprotectin (usually raised in active disease and negative in remission)

Simple imaging like AXR is not commonly done anymore, however if there is suspicion of toxic megacolon it can be done.

Endoscopy

Cross-sectional imaging

Colonoscopy with biopsy is gold standard but not done in acute setting due to risk of perforation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain endoscopy in IBD.

A

Flexible sigmoidoscopy is the safest test in bloody diarrhoea

Colonoscopy is done if you need to look for more proximal disease.

Capsule endoscopy is useful to view the small bowel mucosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain cross-sectional imaging in IBD.

A

CT abdomen when looking for acute complications

MRI enterography when looking for small bowel Crohn’s, fistulas or to map the extent of small bowel Crohn’s.

MRI rectum to image perianal Crohn’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Ulcerative colitis?

A

A relapsing and remitting inflammatory disorder of the colonic mucosa.

It may just affect the rectum (proctitis), or extend to involve part of the colon (left-sided colitis) or the entire colon (pancolitis).

It should never (although it on rare occassions does) spread proximal to the ileocaecal valve.

It does not commonly involve perianal disease (such as Crohn’s can).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cause of ulcerative colitis.

A

Inappropriate immune response against colonic flora in genetically susceptible individuals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathology of UC.

A

Hyperaemic/haemorrhagic colonic mucosa +/- pseudo polyps formed by inflammation.

Punctate ulcers may extend deep into the lamina propria, but the inflammation is not transmural.

Continuous inflammation limited to the mucosa differentiates UC from Crohns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Epidemiology of UC.

A

100-200/100000 in prevalence.

It typicall presents in 20-40 yo.

It is 3 times more common in non-smokers (and the opposite is true for Crohn’s) and symptoms may even relapse on stopping smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Symptoms of UC.

A

Episodic or chronic diarrhoea with or without blood and mucus.

Crampy abdominal discomfort

Bowel frequency related to severity of disease

Urgency/tenesmus (proctitis)

Systemic symtpoms in attacks such as fever, malaise, anorexia, weight loss and fatigue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs of UC.

A

May be none

In acute severe UC there may be fever, tachycardia and tender, distended abdomen.

Extraintestinal signs as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Extraintestinal signs of UC.

A

Clubbing

Skin - Aphthous oral ulcers (pic), Erythema nodosum, Pyoderma gangrenosum

Eyes - Conjunctivitis, Episcleritis, Iritis

Joint - Large joint arthritis, sacroiliitis, ankylosing spondylitis

PSC

Nutritional deficits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Investigations in UC.

A

Bloods- FBC, ESR, CRP, U&Es, LFT and blood culture

Stool MC&S (culture and sensititivty) and CDT (C. diff toxin). This is to exclude Campylobacter, C. diff, Salmonella, Shigella, E. coli and amoebae.

Faecal calprotectin

AXR

Lower GI endoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Findings on AXR in UC.

A

No faecal shadows

Mucosal thickening/islands.

Mural thickening

Thumbprinting (not only seen in UC)

Possible lead pipe colon on enema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain lower GI endoscopy in UC.

A

Limited flexible sigmoidoscopy if acute to assess and biopsy.

Full colonoscopy once controlled to define disease extent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Histology of UC.

A

Expansion of chronic inflammation in the mucosa and, in active cases, the presence of acute inflammation.

In mildly active cases, there is an acute cryptitis that progresses to crypt abscesses in moderately active cases.

In severe cases, mucosal ulcers develop as a result of the ongoing acute inflammatory process. Areas of relatively preserved mucosa between ulcerated areas may have a polypoid appearance grossly and are referred to as “pseudopolyps.” (This is mainly seen macroscopically)

Reduced goblet cells

Non-granulomatous

In cases of many years’ duration, dysplasia of the large bowel mucosa may develop and signifies an increased risk for the development of colorectal adenocarcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is the severity of UC assessed?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acute complications of UC.

A

Toxic dilatation of colon with risk of perforation

Venous thromboembolism (give prophylaxis to all in-patents regardless of rectal bleeding)

Hypokalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chronic complications in UC.

A

Colonic cancer

Lead pipe colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment of mild UC.

A

Remission/induction/maintenance = 5-ASA such as Mesalazine. This is given PR for distal disease or PO for more extensive disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Treatment of moderate UC.

A

If 4-6 motions a day but otherwise well induce remission with oral prednisolone 40mg OD for 1 weak and then taper by 5mg/week overfollowing 7 weeks.

Then go for 5-ASA like Mesalazine for maintenance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Side-effects of 5-ASA.

A

Rash

Haemolysis

Hepatitis

Pancreatitis

Paradoxical worsening of colitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What do all immunosuppressant medications require monitoring of?

A

FBC

U&Es

LFTs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment of severe UC.

A

If unwell and 6 or more motions a day admit the patient.

IV hydration/electrolyte replacement.

IV steroids such as hydrocortisone 100mg/6h or methylprednisolone 40mg/12h.

Thromboembolism prophylaxis

Exclude infection.

25
Q

Monitoring of severe UC.

A

Monitor temp, pulse and BP, record stool charts

Twice-daily exam of abdomen, distension, bowel sounds and tenderness.

Daily FBC, ESR, CRP, U&Es +/- AXR. Consider blood transfusion if anaemic and Hb <80g/L

26
Q

Indications of rescue therapy in UC.

A

If on day 3-5 and CRP is still > 45 or > 6 stools a day.

27
Q

Rescue therapy of UC.

A

Ciclosporin

Infliximab

or

Surgery.

28
Q

If severe UC is improving, how should treatment be altered?

A

Transfer to oral prednisolone 40mg OD.

Schedule maintenance infliximab if used for rescue, or azathioprine if ciclosporin is used for rescue.

29
Q

If treatment fails (even rescue therapy) what should be done?

A

Urgent colectomy by day 7-10.

30
Q

Indications for immunomodulation in UC.

A

Patients falre on steroid tapering or require 2 or more courses of steroids a year.

Azathioprine is used.

31
Q

Indications for biologic therapy in UC.

A

For patients intolerant of immunomodulation or develop symptoms despite an immunomodulator.

Infliximab, adalimumab and golimumab might be used (anti-TNFalpha)

Or adhesion molecules involved in gut lymphocyte trafficking such as vedolizumab.

32
Q

Indications for surgery in UC.

A

This is needed at some tage in 20% of patients.

If there is failure of medical therapy or fulminant colitis with toxic dilation/perforation.

33
Q

Different surgeries in UC.

A

Subtotal colectomy + terminal ileostomy

Completion proctectomy

Ileo-anal anastomosis (J-pouch)

34
Q

What is Crohn’s disease?

A

A chronic inflammatory disease characterised by transmural granulomatous inflammation affecting any part of the gut from mouth to anus. Especially the terminal ileum.

Unlike UC there is unaffected bowel between areas of active disease called skip lesions.

35
Q

Epidemiology of Crohn’s.

A

Prevalence = 100-200/100000

Incidence = 10-20/100000/yr

Typically presents in 20-40 yo

Smoking increases the risk and NSAIDs may exacerbate disease.

36
Q

Symptoms of Crohn’s.

A

Diarrhoea

Abdo pain

Weight loss

Failure to thrive

Systemic symptoms such as fatigue, fever, malaise and anorexia.

37
Q

Signs of Crohn’s disease.

A

Bowel ulceration

Abdominal tenderness/mass

Perianal abscess/fistuale/skin tags

Anal strictures

38
Q

Extra-intestinal signs of Crohn’s.

A

These are ranked commonest to least common.

MSK

Arthritis: colitic type, ankylosing spondylitis, isolated joint involvement

Hypertrophic osteoarthropathy: clubbing, periostitis

Skin

Reactive lesions: erythema nodosum, pyoderma gangrenosum, aphthous ulcers, necrotizingvasculitis

Specific lesions: fissures, fistulas, oral Crohn’s disease, drug rashes

Nutritional deficiencies: acrodermatitis enteropathica, purpura, glossitis, hair loss, brittle nails

Hepatopancreatobiliary system

Primary sclerosing cholangitis, bile-duct carcinoma

Associated inflammation: autoimmune chronic active hepatitis, pericholangitis, portal fibrosis, cirrhosis, granulomatous disease

Metabolic manifestations: fatty liver, gallstones associated with ileal Crohn’s disease

Ocular system

Uveitis/iritis, episcleritis, scleromalacia, corneal ulcers, retinal vascular disease

39
Q

Investigations in Crohn’s.

A

Bloods - FBC, ESR, CRP, U&Es, LFTs, INR, Ferritin, TIBC, B12, Folate

Stool - MC&S and CDT. Faecal calprotectin.

Colonoscopy and biopsy

Capsule endoscopy for small bowel

MRI - to assess pelvic disease and fistulae, small bowel dsiease and strictures.

Enema

40
Q

Histology of Crohn’s

A

The characteristic pattern of inflammation in Crohn disease is a transmural involvement of the bowel wall by lymphoid infiltrates that contains sarcoidlike granulomas in about half of the cases (most commonly in the submucosa).

Paneth cell hyperplasia is frequent and areas of pyloric metaplasia may be seen.

In full-blown cases, long and deep fissure like ulcers form.

41
Q

Non-pharma treatment of Crohn’s.

A

Help quit smoking.

Optimise nutrition

Assess severity by pulse, temp, ESR, WCC, CRP and decreased albumin.

This will guide further treatment.

42
Q

Treatment of mild-moderate Crohn’s.

A

Symptomatic but systemically well.

Prednisolone 40mg OD PO for 1w.

Taper by 5mg every week for next 7w.

Then plan maintenance therapy.

43
Q

Treatment of severe Crohn’s.

A

Admit.

IV hydration/electrolyte replacement

IV steroids e.g. hydrocortisone 100mg/6h or methylprednisolone 40mg/12h.

Thromboembolism prophylaxis

Exclude infection.

44
Q

Monitoring of severe Crohn’s.

A

Temp, pulse, BP and record stool chart.

Physical examination daily.

Daily FBC, ESR, CRP, U&Es and plain AXR.

Consider need for blood transfusion (<80g/L) and nutritional support.

45
Q

Management of severe Crohn’s once improving.

A

Switch to oral prednisolone 40mg OD.

46
Q

Rescue therapy for Crohn’s if things are not improving in severe Crohn’s.

A

Biologics.

Surgery.

47
Q

Different therapies in Crohn’s disease.

A

Azathioprine

Biologics

Nutrition

Surgery

48
Q

Maintenance therapy in Crohn’s.

A

Azathioprine and biologics.

Azathioprine is indicated if refractory to steriods, relapsing on steroid taper or requiring 2+ steroid courses in a year.

Remember to montior FBC, U&Es, LFTs weekly for 4 weeks then every 4 wks for 3 months.

After this at least 3-monthly.

49
Q

Alternative immunomodulators to azathioprine in Crohn’s.

A

6-mercaptopurine

Methotrexate

50
Q

Biologics used in Crohn’s.

A

Anti-TNFalphas like infliximab and adalimumab - should be avoid in underlying malignancy and TB.

Anti-integrins such as vedolizumab.

Anti-IL12/23 such as ustekinumab.

51
Q

Explain nutrition treatment in Crohn’s.

A

Enteral is preferred but consider TPN as a last resort.

Elemtal diets containing amino acids can give remission.

Low residue diets can help symptoms in those with active disease or strictures.

52
Q

Indications for surgery in Crohn’s.

A

Drug failure

GI obstruction from strictures, perforation, fistulae or abscess.

Perianal disease

Growth failure in young people

53
Q

Surgical aims in Crohn’s.

A

Resection of affected areas

Control perianal or fistulising disease

Defunction distal disease with a temporary ileostomy e.g.

54
Q

Explain perianal disease in Crohn’s (does not happen in UC)

A

Occurs in about 50%.

MRI and examination under anaesthetic are an important part of assessment.

55
Q

Treatment of perianal disease in Crohn’s.

A

Oral antibiotics

Immunosuppressant therapy +/- anti-TNFalpha

Local surgery +/- seton insertion.

56
Q

What is the first line of choice medication wise in perianal or fistulating Crohn’s?

A

Biologics

57
Q

Differences between Crohn’s and UC.

A

Crohn’s can affect anywhere from mouth to anus where as UC always affects the rectum and extends proximally.

Crohn’s have skip lesions where as UC is continuous.

Crohn’s has transmural inflammation where as UC has mucosa and submucosal inflammation only.

Crohn’s have fissuring ulcers and non-caseating granulomas where as UC has crypt abscesses.

Crohn’s have lymphoid and neutrophil aggregates as well as cobble-stone appearance.

Crohn’s have perianal disease.

Crohn’s is increased in smokers, UC is decrease in smokers.

58
Q
A